Acid-PEG2-SS-PEG2-acid is a cleavable ADC linker with PEG spacers and disulfide bonds, featuring terminal acid groups for flexible conjugation. Improves solubility and enables controlled drug release in antibody-drug conjugates.
Structure of 1807539-10-1
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Acid-PEG2-SS-PEG2-acid, a versatile bifunctional reagent, finds diverse applications in bioconjugation and drug delivery. Here are four key applications presented with high perplexity and burstiness://
Antibody-Drug Conjugates: Utilizing Acid-PEG2-SS-PEG2-acid, researchers forge a crucial link between therapeutic agents and antibodies to create potent antibody-drug conjugates (ADCs). These specialized conjugates target cancer cells with pinpoint accuracy, ushering in a new era of precision cytotoxic drug delivery. This targeted delivery strategy minimizes harm to healthy tissues while maximizing the efficacy of anti-cancer treatments.
Protein-Protein Crosslinking: Through the artful crosslinking of proteins, Acid-PEG2-SS-PEG2-acid facilitates in-depth exploration of protein interactions and intricate complex formations. By establishing robust disulfide bonds between proteins, scientists can dissect protein assemblies using cutting-edge tools like mass spectrometry and X-ray crystallography. This wealth of information is indispensable for unraveling the mysteries of protein functions and interplays within cellular dynamics.
Controlled Drug Release: Delving into the realm of drug delivery systems, Acid-PEG2-SS-PEG2-acid plays a pivotal role in engineering platforms with finely tuned release mechanisms. The sensitive disulfide linkage within this compound responds to the reductive milieu inside cells, orchestrating the precise release of therapeutic payloads at designated sites. This targeted drug release paradigm heightens treatment efficacy, narrowing the therapeutic window and diminishing adverse effects associated with systemic drug circulation.
Surface Modification: In the realm of material science, Acid-PEG2-SS-PEG2-acid emerges as a transformative tool for surface engineering of nanoparticles and diverse materials. By grafting functional moieties onto surfaces, researchers sculpt material properties to cater to biomedical applications such as precision drug delivery and biosensing. This tailored surface modification strategy elevates the biocompatibility and performance benchmarks of nanomaterials across a spectrum of cutting-edge applications.
Catalog | Product Name | CAS | Inquiry |
---|---|---|---|
BADC-01037 | Acid-PEG3-SS-PEG3-acid | 2055014-98-5 | |
BADC-01198 | Acid-PEG1-bis-PEG3-BCN |
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.